Serous atrophy of bone marrow

Changed by Joshua Yap, 3 Oct 2022
Disclosures - updated 15 Jul 2022: Nothing to disclose

Updates to Article Attributes

Body was changed:

Serous atrophy of bone marrow is a non-neoplastic bone marrow disorder that occurs with chronic illness and poor nutritional status. It is characterizedcharacterised by atrophy of the fatty marrow and loss of hematopoietichaematopoietic cells, replaced by an accumulation of extracellular mucinous substances.

Terminology

Serous atrophy of bone marrow is the preferred term for this disorder, which has also been termed gelatinous marrow transformation 7.  

Clinical presentation

Patients can develop osteoporosis and may present with insufficiency fractures. 

Pathology

Serous atrophy can be evident in:

Radiographic features

RadiographsPlain radiograph
  • severe soft tissue wasting 

CT
  • subcutaneous and visceral fat are nearly absent

MRI

MRI shows striking changes in the fat. Fluid intensity regions in the marrow that are initially patchy but become confluent. These progress in the same order as red to yellow marrow conversion: distal extremities to proximal extremities and axial skeleton. Similar signal abnormalities can usually be observed in the adjacent subcutaneous fat 6.

  • T1: mildly low signal intensity

  • STIR: high signal intensity

  • T1 C+ (Gd): non-enhancing bone marrow 

Practical points

  • knowledge of this condition is important so as not to subject the patient to a repeat MRI out of concern that the study is technically faulty

  • visceral and subcutaneous fat are nearly absent, which should alert the interpreter to the condition

  • serous marrow does not enhance, differentiating from a diffuse infiltrating malignancy which will enhance after contrast administration 7

  • serous marrow is often associated with insufficiency fractures, which may be obscured on MRI by the abnormal bone marrow signal

  • CT can be used as a problem-solving tool to further assess for an insufficiency fracture that cannot be visualizedvisualised on MRI

  • -<p><strong>Serous atrophy of bone marrow</strong> is a non-neoplastic bone marrow disorder that occurs with chronic illness and poor nutritional status.  It is characterized by atrophy of the fatty marrow and loss of hematopoietic cells, replaced by an accumulation of extracellular mucinous substances.</p><h4>Terminology</h4><p>Serous atrophy of bone marrow is the preferred term for this disorder, which has also been termed gelatinous marrow transformation <sup>7</sup>.  </p><h4>Clinical presentation</h4><p>Patients can develop <a href="/articles/osteoporosis-3">osteoporosis</a> and may present with <a href="/articles/insufficiency-fracture">insufficiency fractures.</a> </p><h4>Pathology</h4><p>Serous atrophy can be evident in:</p><ul>
  • -<li><a href="/articles/cachexia">cachexia</a></li>
  • -<li>
  • -<a href="/articles/anorexia-nervosa">anorexia nervosa</a> or other eating disorders</li>
  • -<li><a href="/articles/hivaids">AIDS</a></li>
  • -<li>alcohol excess</li>
  • -<li>acute febrile illness</li>
  • -<li>malignancies</li>
  • -<li><a href="/articles/chronic-kidney-disease">chronic renal failure</a></li>
  • -<li><a href="/articles/congestive-cardiac-failure">congestive heart failure</a></li>
  • -<li><a href="/articles/myelodysplastic-syndrome">myelodysplastic syndrome</a></li>
  • -</ul><h4>Radiographic features</h4><h5>Radiographs</h5><ul><li>severe soft tissue wasting </li></ul><h5>CT</h5><ul><li>subcutaneous and visceral fat are nearly absent</li></ul><h5>MRI</h5><p>MRI shows striking changes in the fat. Fluid intensity regions in the marrow that are initially patchy but become confluent. These progress in the same order as red to yellow <a href="/articles/bone-marrow">marrow conversion</a>: distal extremities to proximal extremities and <a href="/articles/axial-skeleton">axial skeleton</a>. Similar signal abnormalities can usually be observed in the adjacent subcutaneous fat <sup>6</sup>.</p><ul>
  • -<li>
  • -<strong>T1:</strong> mildly low signal intensity</li>
  • -<li>
  • -<strong>STIR:</strong> high signal intensity</li>
  • -<li>
  • -<strong>T1 C+ (Gd):</strong> non-enhancing bone marrow </li>
  • +<p><strong>Serous atrophy of bone marrow</strong> is a non-neoplastic bone marrow disorder that occurs with chronic illness and poor nutritional status. It is characterised by atrophy of the fatty marrow and loss of haematopoietic cells, replaced by an accumulation of extracellular mucinous substances.</p><h4>Terminology</h4><p>Serous atrophy of bone marrow is the preferred term for this disorder, which has also been termed gelatinous marrow transformation <sup>7</sup>.  </p><h4>Clinical presentation</h4><p>Patients can develop <a href="/articles/osteoporosis-3">osteoporosis</a> and may present with <a href="/articles/insufficiency-fracture">insufficiency fractures.</a> </p><h4>Pathology</h4><p>Serous atrophy can be evident in:</p><ul>
  • +<li><p><a href="/articles/cachexia">cachexia</a></p></li>
  • +<li><p><a href="/articles/anorexia-nervosa">anorexia nervosa</a> or other eating disorders</p></li>
  • +<li><p><a href="/articles/hivaids">AIDS</a></p></li>
  • +<li><p>alcohol excess</p></li>
  • +<li><p>acute febrile illness</p></li>
  • +<li><p>malignancies</p></li>
  • +<li><p><a href="/articles/chronic-kidney-disease">chronic renal failure</a></p></li>
  • +<li><p><a href="/articles/congestive-cardiac-failure">congestive heart failure</a></p></li>
  • +<li><p><a href="/articles/myelodysplastic-syndrome">myelodysplastic syndrome</a></p></li>
  • +</ul><h4>Radiographic features</h4><h5>Plain radiograph</h5><ul><li><p>severe soft tissue wasting </p></li></ul><h5>CT</h5><ul><li><p>subcutaneous and visceral fat are nearly absent</p></li></ul><h5>MRI</h5><p>MRI shows striking changes in the fat. Fluid intensity regions in the marrow that are initially patchy but become confluent. These progress in the same order as red to yellow <a href="/articles/bone-marrow">marrow conversion</a>: distal extremities to proximal extremities and <a href="/articles/axial-skeleton">axial skeleton</a>. Similar signal abnormalities can usually be observed in the adjacent subcutaneous fat <sup>6</sup>.</p><ul>
  • +<li><p><strong>T1:</strong> mildly low signal intensity</p></li>
  • +<li><p><strong>STIR:</strong> high signal intensity</p></li>
  • +<li><p><strong>T1 C+ (Gd):</strong> non-enhancing bone marrow </p></li>
  • -<li>knowledge of this condition is important so as not to subject the patient to a repeat MRI out of concern that the study is technically faulty</li>
  • -<li>visceral and subcutaneous fat are nearly absent, which should alert the interpreter to the condition</li>
  • -<li>serous marrow does not enhance, differentiating from a diffuse infiltrating malignancy which will enhance after contrast administration <sup>7</sup>
  • -</li>
  • -<li>serous marrow is often associated with <a href="/articles/insufficiency-fracture">insufficiency fractures</a>, which may be obscured on MRI by the abnormal bone marrow signal</li>
  • -<li>CT can be used as a problem-solving tool to further assess for an insufficiency fracture that cannot be visualized on MRI</li>
  • +<li><p>knowledge of this condition is important so as not to subject the patient to a repeat MRI out of concern that the study is technically faulty</p></li>
  • +<li><p>visceral and subcutaneous fat are nearly absent, which should alert the interpreter to the condition</p></li>
  • +<li><p>serous marrow does not enhance, differentiating from a diffuse infiltrating malignancy which will enhance after contrast administration <sup>7</sup></p></li>
  • +<li><p>serous marrow is often associated with <a href="/articles/insufficiency-fracture">insufficiency fractures</a>, which may be obscured on MRI by the abnormal bone marrow signal</p></li>
  • +<li><p>CT can be used as a problem-solving tool to further assess for an insufficiency fracture that cannot be visualised on MRI</p></li>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.